Trials / Suspended
SuspendedNCT00566514
The Role of Ribose in Patients Diagnosed With Fibromyalgia
The Role of D-RIbose in Patients Diagnosed With Fibromyalgia
- Status
- Suspended
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Bioenergy Life Science, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 78 Years
- Healthy volunteers
- Not accepted
Summary
The purose of this research study is to determine the potential benefit of D-ribose, a nutritional supplement (a sugar), versus a placebo (another sugar) in people with fibromyalgia.
Detailed description
Two hundred to three hundred subjects (equally distribued between placebo and D-ribose) between 18-78 years of age will comprise this study. The final numbers enrolled will depend upon obtaining approximately 100 subjects that can display a high degree of compliance to TID dosing with approximately equal balance between the active and placebo arms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | D-ribose | 5 grams administered orally TID |
| OTHER | dextrose | 5 grams orally TID |
Timeline
- Start date
- 2006-07-01
- Primary completion
- 2008-07-01
- Completion
- 2008-07-01
- First posted
- 2007-12-03
- Last updated
- 2008-03-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00566514. Inclusion in this directory is not an endorsement.